CA2489368C - Mitral valve annuloplasty ring having a posterior bow - Google Patents
Mitral valve annuloplasty ring having a posterior bow Download PDFInfo
- Publication number
- CA2489368C CA2489368C CA2489368A CA2489368A CA2489368C CA 2489368 C CA2489368 C CA 2489368C CA 2489368 A CA2489368 A CA 2489368A CA 2489368 A CA2489368 A CA 2489368A CA 2489368 C CA2489368 C CA 2489368C
- Authority
- CA
- Canada
- Prior art keywords
- ring
- posterior
- section
- bow
- ring body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
- A61F2/2448—D-shaped rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
Abstract
A mitral heart valve annuloplasty ring (30) having a posterior bow that conforms to an abnormal posterior aspect of the mitral annulus. The ring (30) may be generally oval having a major axis and a minor axis, wherein the posterior bow may be centered along the minor axis or offset in a posterior section (36). The ring may be substantially planar, or may include upward bows on either side of the posterior bow. The ring may include a ring body (30) surrounded by a suture-permeable fabric sheath, and the ring body may be formed of a plurality of concentric ring elements (70a,70b,70c,70d). The ring is semi-rigid and the posterior bow is stiff enough to withstand deformation once implanted and subjected to normal physiologic stresses. The ring elements (70a,70b,70c,70d) may be bands of semi-rigid material. A method of repairing an abnormal mitral heart valve annulus having a depressed posterior aspect includes providing a ring with posterior bow and implanting the ring to support the annulus without unduly stressing the attachment sutures.
Description
BOW
FIELD OF THE INVENTION
The present invention relates generally to medical devices, specifically to an annuloplasty ring and related procedure for surgically reconstructing the mitral valve annulus of a patient's heart. More specifically, this invention relates to a mitral valve repair device and corresponding technique that conforms to an abnormal annulus in the pathology encountered with functional mural regurgitation having a posterior aspect depressed below the anterior aspect.
BACKGROUND OF THE INVENTION
In the anatomy of the human heart, the left atrium receives oxygenated blood from the lungs through the pulmonary vein. The mural valve separates the left atrium from the left ventricle. During diastole, as the contraction triggered by the sinoatrial node progresses through the atria, oxygenated blood passes through the mural valve into the left ventricle. In this phase, the aortic valve leading into the ascending aorta closes, allowing the left ventricle to fill with blood. A similar flow of venous blood occurs from the right atrium through the pulmonary valve to the right ventricle. Once the ventricles are full, they contract during the systolic phase and pump blood out of the heart.
During systole, the mural valve closes and the aortic valve opens, thus preventing blood from regurgitating into the left atrium and forcing blood into the aorta, and from there throughout the body. Because of the high pressures associated with the left ventricle during systole, proper functioning of the mural valve to prevent blood from flowing back through the system is extremely important.
The various anatomical components of the left venh~icle LV and mural valve MV are depicted in Fig. 1 as seen in vertical cross-section along an anterior-posterior plane. The mural annulus MA comprises a fibrous ring
FIELD OF THE INVENTION
The present invention relates generally to medical devices, specifically to an annuloplasty ring and related procedure for surgically reconstructing the mitral valve annulus of a patient's heart. More specifically, this invention relates to a mitral valve repair device and corresponding technique that conforms to an abnormal annulus in the pathology encountered with functional mural regurgitation having a posterior aspect depressed below the anterior aspect.
BACKGROUND OF THE INVENTION
In the anatomy of the human heart, the left atrium receives oxygenated blood from the lungs through the pulmonary vein. The mural valve separates the left atrium from the left ventricle. During diastole, as the contraction triggered by the sinoatrial node progresses through the atria, oxygenated blood passes through the mural valve into the left ventricle. In this phase, the aortic valve leading into the ascending aorta closes, allowing the left ventricle to fill with blood. A similar flow of venous blood occurs from the right atrium through the pulmonary valve to the right ventricle. Once the ventricles are full, they contract during the systolic phase and pump blood out of the heart.
During systole, the mural valve closes and the aortic valve opens, thus preventing blood from regurgitating into the left atrium and forcing blood into the aorta, and from there throughout the body. Because of the high pressures associated with the left ventricle during systole, proper functioning of the mural valve to prevent blood from flowing back through the system is extremely important.
The various anatomical components of the left venh~icle LV and mural valve MV are depicted in Fig. 1 as seen in vertical cross-section along an anterior-posterior plane. The mural annulus MA comprises a fibrous ring
2 encircling the orifice between the left atrium LA and the left ventricle LV.
The average human mural annular cross-sectional area is 5-11 cm2. The anterior aspect of the mural annulus MA forms a part of the "cardiac skeleton" and includes left and right fibrous trigones, LT and RT. Fig. 3 illustrates the mural valve from the left atrium as exposed during surgery. The mural valve is a bicuspid valve having a posterior leaflet PL that cooperates with an anterior leaflet AL. The left trigone LT and right trigone RT are indicated at the junction points of the anterior leaflet AL and posterior leaflet PL. These junction points are also known as connnissures between the leaflets. The posterior aspect of the mitral annulus MA, in contrast to the anterior aspect, consists mainly of muscular tissue of the outer wall of the heart.
With reference again to Fig. l, a pair of papillary muscles P, and PZ
attach to the lower portion of the interior wall of the left ventricle LV.
Chordae tendineae CT extend between and link the papillary muscles P, and PZ and free edges of the anterior and posterior leaflets AL and PL. The chordae tendineae are string-like in appearance and are sometimes referred to as "heart strings."
Although not shown in the drawing, chordae tendoneae CT extend between each of the papillary muscles P1 and PZ and both leaflets. Contraction of the papillary muscles 1', and PZ pulls the chordae tendoneae CT, which in turn pull the leaflets open, and when the muscles relax the chordae tendonae become slack, allowing the leaflets to come together or "coapt." As seen in Fig. 1, the leaflets coapt along a substantial surface area in the normal functioning heart, with the free edges of the leaflets mutually bending toward the left ventricle LV.
As seen in Fig. 1, and for purpose of discussion, the mural annulus MA
of a normal, healthy heart lies generally in a datum plane 20 defined perpendicular to the average blood flow direction 22 through the mural valve MV. Although a typical mural annulus MA may be three-dimensional, the datum plane 20 is representative of the relative positions of the anterior and posterior side of the annulus.
The average human mural annular cross-sectional area is 5-11 cm2. The anterior aspect of the mural annulus MA forms a part of the "cardiac skeleton" and includes left and right fibrous trigones, LT and RT. Fig. 3 illustrates the mural valve from the left atrium as exposed during surgery. The mural valve is a bicuspid valve having a posterior leaflet PL that cooperates with an anterior leaflet AL. The left trigone LT and right trigone RT are indicated at the junction points of the anterior leaflet AL and posterior leaflet PL. These junction points are also known as connnissures between the leaflets. The posterior aspect of the mitral annulus MA, in contrast to the anterior aspect, consists mainly of muscular tissue of the outer wall of the heart.
With reference again to Fig. l, a pair of papillary muscles P, and PZ
attach to the lower portion of the interior wall of the left ventricle LV.
Chordae tendineae CT extend between and link the papillary muscles P, and PZ and free edges of the anterior and posterior leaflets AL and PL. The chordae tendineae are string-like in appearance and are sometimes referred to as "heart strings."
Although not shown in the drawing, chordae tendoneae CT extend between each of the papillary muscles P1 and PZ and both leaflets. Contraction of the papillary muscles 1', and PZ pulls the chordae tendoneae CT, which in turn pull the leaflets open, and when the muscles relax the chordae tendonae become slack, allowing the leaflets to come together or "coapt." As seen in Fig. 1, the leaflets coapt along a substantial surface area in the normal functioning heart, with the free edges of the leaflets mutually bending toward the left ventricle LV.
As seen in Fig. 1, and for purpose of discussion, the mural annulus MA
of a normal, healthy heart lies generally in a datum plane 20 defined perpendicular to the average blood flow direction 22 through the mural valve MV. Although a typical mural annulus MA may be three-dimensional, the datum plane 20 is representative of the relative positions of the anterior and posterior side of the annulus.
3 In many developed countries, congestive heart failure is a leading cause of hospitalization and death, and its incidence is increasing. When imperfections in the mural valve allows blood to flow backward into the left atrium, known as secondary mural regurgitation, the left ventricle must pump progressively harder to circulate blood throughout the body, which in turn promotes congestive heart failure. 1-Ieal-t transplantation is considered a standard treatment for select patients with severe congestive heart failure and end-stage heart disease, but only a small number of donor hearts are available and there are severe surgical risks for weaker patients. Accordingly, alternative medical and surgical strategies are evolving to treat such conditions.
One typical cause of mural regurgitation is malformation of the mitral annulus MA along the more flexible posterior aspect of the annulus. As seen in Fig. 2, some patients experience a depression 1~ of the posterior aspect of the annulus caused by dilation of the left ventricle LV. Dilation of the left ventricle LV is a symptom associated with mural regurgitation in patients with iopathic dilated cardiomyopathy or ischemic cardiomyopathy, and in patients with long-standing valvular regurgitation from other etiologies such as myxomatous disease, endocarditis, congenital defects, or rheumatic valvular disease. Fig.
illustrates the subsequent loss of coaptation between the posterior and anterior leaflets AL and PL from this posterior aspect depression, as seen from above.
As seen in Fig. 2, dilation of the left ventricle LV generally increases the distance between the papillary muscles Pi and PZ and the mitral annulus MA.
This in turn increases the tension in the chordae tendonae CT. The droop or depression of the posterior aspect of the annulus below the datum plane 20 by the distance h 111 COlllblllatloll Wlth the increased tenS1011 Ill the chordae reduces the ability of the leaflets to come together during systole.
Various interventions have been used to alter the size of the regurgitant orifice area. Annuloplasty rings have been developed in various shapes and configurations over the years to correct mural regurgitation and other conditions which reduce the functioning of the valve. For example, Carpentier, et al. in
One typical cause of mural regurgitation is malformation of the mitral annulus MA along the more flexible posterior aspect of the annulus. As seen in Fig. 2, some patients experience a depression 1~ of the posterior aspect of the annulus caused by dilation of the left ventricle LV. Dilation of the left ventricle LV is a symptom associated with mural regurgitation in patients with iopathic dilated cardiomyopathy or ischemic cardiomyopathy, and in patients with long-standing valvular regurgitation from other etiologies such as myxomatous disease, endocarditis, congenital defects, or rheumatic valvular disease. Fig.
illustrates the subsequent loss of coaptation between the posterior and anterior leaflets AL and PL from this posterior aspect depression, as seen from above.
As seen in Fig. 2, dilation of the left ventricle LV generally increases the distance between the papillary muscles Pi and PZ and the mitral annulus MA.
This in turn increases the tension in the chordae tendonae CT. The droop or depression of the posterior aspect of the annulus below the datum plane 20 by the distance h 111 COlllblllatloll Wlth the increased tenS1011 Ill the chordae reduces the ability of the leaflets to come together during systole.
Various interventions have been used to alter the size of the regurgitant orifice area. Annuloplasty rings have been developed in various shapes and configurations over the years to correct mural regurgitation and other conditions which reduce the functioning of the valve. For example, Carpentier, et al. in
4 U.S. Patent No. 4,055,861 disclosed two semi-rigid supports for heart valves, one of which being closed (or D-shaped) and the other being open (or C-shaped). In the closed configuration, the ring is generally symmetric about an anterior-posterior plane, and has a convex posterior side and a generally straight anterior side. U.S. Patent Nos. 5,104,407, 5,201,880, and 5,607,471 all disclose closed annuloplasty rings that are bowed slightly upward on their anterior side.
Because the anterior aspect of the mural annulus MA is fibrous and thus relatively inflexible (at least in comparison to the posterior aspect), the upward curve in the anterior side of each ring conforms that ring more closely to the anatomical contour of the mitral annulus, and thus reduces undue deformation of the annulus.
In general, conventional annuloplasty rings are intended to restore the original configuration of the mural annulus MA, or in other words bring the annulus as close as possible back to the datum plane 20 as seen in Fig. 1.
When correcting a condition as seen in Fig. 2, high stresses are created in the sutures connecting the annuloplasty ring to posterior aspect of the annulus because the ring "pulls" the annulus upward. The stresses sometimes result in the dehiscence or separation of the ring from the annulus at this location because the sutures pull through the tissue.
It should be noted here that correction of the aortic annulus requires a much different ring then with a mitral a11111I11IS. For example, U.S. Patent Nos.
Because the anterior aspect of the mural annulus MA is fibrous and thus relatively inflexible (at least in comparison to the posterior aspect), the upward curve in the anterior side of each ring conforms that ring more closely to the anatomical contour of the mitral annulus, and thus reduces undue deformation of the annulus.
In general, conventional annuloplasty rings are intended to restore the original configuration of the mural annulus MA, or in other words bring the annulus as close as possible back to the datum plane 20 as seen in Fig. 1.
When correcting a condition as seen in Fig. 2, high stresses are created in the sutures connecting the annuloplasty ring to posterior aspect of the annulus because the ring "pulls" the annulus upward. The stresses sometimes result in the dehiscence or separation of the ring from the annulus at this location because the sutures pull through the tissue.
It should be noted here that correction of the aortic annulus requires a much different ring then with a mitral a11111I11IS. For example, U.S. Patent Nos.
5,258,021 and 6,231,602 disclose sinusoidal or so-called "scalloped"
annuloplasty rings that follow the up-and-down shape of the three cusp aortic annulus. Such rings would not be suitable for cowecting a mitral valve deficiency.
While good results in the treatment of congestive heart failure and mural regurgitation have been obtained in the preliminary applications of the above-described methods and apparatuses, it is believed that these results can be significantly improved. Specifically, it would be desirable to produce a mitral annuloplasty ring that can reduce stresses associated with the implantation of conventional rings.
Summary of the Invention 5 The present invention provides an annuloplasty ring for implantation in a mural valve annulus that has a pathologic condition such that the posterior aspect thereof droops downward abnormally. The annuloplasty ring includes a rounded ring body having an anterior section and a posterior section. The ring body is oriented about a central flow axis that defines an upward direction and a downward direction, the downward direction corresponding to the direction of blood flow through the mural valve annulus. The posterior section the ring body bows downward out of a plane perpendicular to the central flow axis.
The ring body may bow downward between about 2-15 mm from one end thereof to a lowest point, and desirably bows downward between about 4-8 mm from one end thereof to a lowest point. The bow in the ring body may or may not be centered in the posterior section. Preferably, the ring body is made of a malleable material such that the bow in the ring body may be manually reshaped. Desirably, the ring body is made of a semi-rigid material that will retain its posterior bow in opposition to the stresses that will be imparted by muscles of the heart throughout each beating cycle. The ring body may be substantially planar except in the posterior section, or an anterior section of the ring body may bow upward from one end thereof to a lowest point.
In plan view, as seen along the flow axis, the ring body preferably defines an oval shape with a major axis perpendicular to a minor axis, the minor axis bisecting both the anterior and posterior sections. Further, the bow in the posterior section may begin at synnnetric locations across the minor axis that are spaced from the major axis around the ring body by an angle 0 of between about 0-45°, more preferably about 30°.
The ring body may further include two upward bows on either side of the downward bow on the posterior section, and wherein downward bow may G
be between about 2-15 mm. In one embodiment, the ring body comprises a plurality of ring elements concentrically disposed. A polymer strip in between each ring element may be provided. Optionally, the ring elements comprise bands that have a substantially larger height in the flow axis dimension than in the dimension perpendicular to the flow axis. Further, the ring elements may have varying heights so that. the ring body is more flexible in the posterior section than around the remainder of the ring body.
Another aspect of the present invention is a method of repairing a mural heart valve annulus that has a posterior aspect that is depressed downward along the blood flow axis relative to an anterior aspect. The method includes implanting an annuloplasty ring having an anterior section sized to fit the anterior aspect of the annulus and a posterior section sized to the posterior aspect, wherein the ring posterior section bows downward parallel to the central axis relative to the anterior section. The annuloplasty ring may be malleable and the surgeon adjusts the bow in the posterior section manually.
Another aspect of the invention is a method of repairing a mural heart valve annulus that has a posterior aspect, an anterior aspect, and a blood flow axis. The method includes inspecting the shape of the mural annulus and selecting a three-dimensional annuloplasty ring based on the shape of the mural annulus. The selected annuloplasty ring has an anterior section and a posterior section generally arranged around a central axis. The central axis defines an upward direction and a downward direction, wherein the ring posterior section bows downward out of a plane perpendicular to the central axis. The method includes implanting the annuloplasty ring so that the ring posterior section attaches to the posterior aspect of the mural valve annulus and the posterior section bows in the blood flow direction.
Brief Description of the Drawings Fig. 1 is a cross-section of a healthy left ventricle through the mural valve between the anterior and posterior leaflets;
Fig. 2 is a cross-section of a dilated left ventricle through the mural valve between the anterior and posterior leaflets;
Fig. 3 is an atrial view of the mural valve of Fig. 2 exposed during a surgical procedure;
Fig. 4 is a plan view of annuloplasty ring of the present invention implanted so as to restore competency to the mitral valve;
Fig. 5 is a perspective view of an annuloplasty ring of the present invention over an abnormal mural valve as viewed from the posterior side;
Fig. 6 is a perspective view of the annuloplasty ring of Fig. 5 over the abnormal mural valve as seen from the side;
Figs. 7A-7C are plan, front, and side views of an exemplary annuloplasty ring of the present invention having a posterior bow;
Figs. 8A-8C are plan, front, and side views of an alternative annuloplasty ring of the present invention having a posterior bow between two raised portions;
Figs 9A and 9B are front and side elevational views, respectively, of an inner ring body of a further annuloplasty ring of the present invention having an off center posterior bow and an anterior bow; and Fig. 10 is a top plan view of an inner ring body of an annuloplasty ring of the present invention showing details of a composite band construction.
DESCRIPTION OF THE PREFERRED EMBODIMENTS.
The attached figures illustrate several exemplary embodiments of the annuloplasty ring of the present invention, which can be described as being continuous and having an anterior side, a posterior side and right and left sides.
All of the sides are generally curvilinear with no specific demarcations to indicate abrupt transitions therebetween. Rather, smooth transitional sections between the adjacent sides provide curvilinear connections that give the ring a generally rounded (e.g., oval) configuration.
An exemplary annuloplasty ring 30 of the present invention is shown in Fig. 4 implanted around a mural annulus MA. As described above, the mural annulus has an anterior leaflet AL and a posterior leaflet PL. When the ring is implanted, the leaflets are brought closer together and supported so that they meet at a coaptation surface 32. The ring 30 thus corrects the problem of functional mural regurgitation.
The ring 30 has an oval or somewhat D-shaped configuration with a relatively straight anterior section 34 opposite a curved posterior section 36. A
pair of trigone or commissure markers 38a, 38b generally delimit the anterior side 34, while a pair of opposed side sections 40a, 40b extend between each of these markers and the posterior section 36. A plurality of knotted suture loops 42 are typically used to secure the ring 30 to the mitral annulus MA, although other fasteners such as staples, fibrin glue, or the like may be used.
In the pathological conditions for which the annuloplasty ring 30 is best suited, the posterior aspect of the mural annulus is depressed relative to the anterior aspect, as is illustrated in Fig. 2. In the view of Fig. 4, the posterior aspect will be depressed into the page relative to the anterior aspect. The annuloplasty ring 30 of the present invention has a shaped posterior section that generally follows the modified shape of the mural annulus MA. In other words, the posterior section 36 is bowed into the page relative to the anterior section 34. When secured in place with sutures 42, for example, the ring 30 supports the mitral annulus MA in its modified shape, rather than trying to revert the annulus back to the original substantially planar configuration. At the same time, the ring 30 desirably constricts the orifice circumference defined by the annulus so as to bring the anterior leaflet AL and posterior leaflet PL
closer together. Because the ring 30 does not pull the posterior aspect of the mural annulus MA upward from its modified position, high stresses are not set up in the attachment sutures 42 and thus there is less potential for the dehiscence.
Figs. S and 6 illustrate the exemplary annuloplasty ring 30 in perspective above a mural annulus that is depressed on its posterior side. The bow of the ring 30 in its posterior section 36 is seen best in Fig. 6 mimicking the depression of the posterior aspect of the mural annulus MA in the pathology encountered with functional mitral regurgitation.
The exemplary annuloplasty ring 30 of Figs. 4-6 is shown in more detail in Figs. 7A-7C. The ring 30 is shown complete with a fabric covering. For purpose of orientation, Fig. 7A illustrates orthogonal axes wherein the X- and Y-axes generally define the datum plane 20 as mentioned above with respect to Figs. 1 and 2. The X-axis extends across the ring 30 from one side 40a to the opposite side 40b at the point of maximum dimension. The X-axis thus defines a major axis of the ring 30. The Y-axis defines a plane of symmetry for the ring 30 extending between a midpoint of the anterior side 34 to a midpoint of the posterior section 3G. The Y-axis also defines a minor axis for the ring 30.
As with many conventional rings, the ratio of the minor axis dimension to the major axis dimension is desirably about 3:4. This size ratio is the "classic" shape of the mural annulus, and may be the best configuration of the annuloplasty ring 30. However, it is contemplated that other shapes that have smaller minor axis-to-major axis ratios may actually increase leaflet coaptation.
Although not geometrically precise, the non-circular ring configuration may be considered oval, elliptical or D-shaped. It should be noted that the present invention could also take the form of a discontinuous ring that has a C-shape, for example. The break in such a ring may be in the anterior section, and the posterior section is continuous and exhibits the downward bow as explained.
The Z-axis in Fig. 7B lies along of the axis of blood flow through the ring 30 when implanted, and it will be understood that the positive Z
direction is the "upward" direction, the negative Z direction is the "downward" direction, and the ring 30 is designed to be implanted in a mural annulus such that blood will flow in the downward direction.
Several points are noted around the ring 30 to help describe the posterior bow. These points, and the ones shown in Figs. 8A-8B, are imaginary center points through the cross-section of the ring 30. Two points A are symmetrically located on either side of the Y-axis at an angular distance 0 from the X-axis.
The midpoint of the posterior section 3G is denoted B. The ring 30 has a posterior bow such that the point B is at the lowest elevation along the Z-axis.
The magnitude of this posterior bow is indicated by the dimension Z, in Fig.
5 7C. The points A on either side of the posterior section 3G represent the location where the posterior bow begins. That is, except for the posterior section, the ring 30 is preferably substantially planar. However, the anterior section 34 can optionally be bowed upward by a distance of between about 2-4 mm (0.08-0.1 G inches), as in certain rings of the prior art. In the latter example, 10 the posterior section 36 bows downward in the Z-direction relative to the elevation of the trigone markers 38a, 38b.
Various possible configurations for the ring 30 as seen in Figs. 7A-7C
are contemplated, with the dimension Z, and the angle 8 varying between ranges determined by the overall size of the mural annulus, the extent of anatomical droop of the posterior aspect, and various other factors including surgeon preference. Nevertheless, certain ranges are believed suitable to support and correct a majority of the patients exhibiting the particular anatomical irregularity as described herein. The downward bow or posterior bow preferably extends along a majority of the posterior section 3G between the points A, which points are between 0 and 45° from the X-axis (0). More preferably, the points A are between 20-40°, and more particularly about 30°
from the X-axis. The magnitude of bow Z, may be between about 2-15 mm (0.08-0.59 inches), and more typically is between about 4-8 mm (0.1 G-0.31 inches), depending on the size of the ring.
Although the ring 30 is shown in Figs. 7A-7C as symmetric about the Y-axis, it does not necessarily have to be so. For example, the point B may be displaced from the Y-axis such that the downward bow is not centered in the posterior section 3G. An asymmetric ring is shown and described below with reference to Figs. 9A and 9B.
Figs. 8A-8C illustrate an alternative annuloplasty ring 50 of the present invention that has both upward and downward bows. Again, the ring 50 is shown complete with a fabric covering. The ring 50 includes an anterior section 52, a posterior section 54, and a pair of side sections (not numbered) therebetween. The ring 50 is generally planar on the anterior section 52 and shaped on the posterior section 54. The points A symmetrically disposed across the Y-axis again denote the locations on each side where the ring 50 begins to curve out of a plane. In this embodiment, the ring curves upward in the Z-direction from the points A, as best seen in Fig. 8B, to high points C, and then dips downward to the midpoint B of the posterior section 54. The downward bow of the ring between points A and Q is shown in Fig. 8C as the dimension Zz, which has a magnitude similar to that given for Z, in Fig. 7C. The upward curve may be selected so as to better match the patient's annulus shape.
Furthermore, the anterior section 52 may be upwardly bowed by a distance of between about 2-4 mm (0.08-0.16 inches).
Various permutations of the ring 50 shown in Figs. 8A-8C are contemplated, with the dimensions being altered based on numerous factors. In an exemplary embodiment, the points A are desirably disposed an angular distance oc from the X-axis of between about 0-15°, and more desirably between about 5-10". The points C of 111aXlllll1111 height of the ring 50 are preferably spaced an angular distance [3 from the X-axis of between about 15-45", and more preferably between about 25-35°. The lowest point B of the ring 50 may be bowed along the Z-axis as in the embodiment of Figs. 7A-7C, so that, as indicated Fig. 8C, Zz is desirably between about 2-15 171111 (0.08-0.59 inches), and more typically is between about 4-8 171111 (0.16-0.31 inches), depending on the size of the ring. Therefore, the total height of the ring 50 is at least 2 mm, and may be greater than 15 mm.
Figs. 9A and 9B show an inner ring body 60 for use in an annuloplasty ring of the present invention. The ring body 60 has a posterior bow 62 that is offset from the center of a posterior section 64. In the illustrated embodiment, the bow 62 is offset toward the posterio-medial side (to the right) by about 20%
of the entire major axis width of the ring body 60. Another way to state the offset is that, in plan view, the bow G2 is centered at a clock position, with 12:00 being centered in the anterior side. In that sense, the bow 62 is centered between 3:00 and 6:00, and more preferably is centered at about 5:00. The axial bow Z3 is shown and may vary from about 2.0 mm (0.08 inches) to about 4.0 mm (0.1 G inches), and more preferably from about 3.0 mm (0.12 inches) to about 3.8 mm (0.15 inches), depending on ring size. In addition, the ring body 60 has an anterior section 6G that is upwardly bowed by a distance of between about 2-4 mm (0.08-0.1 G inches).
The inner ring body 60 demonstrates an asymmetric ring that conforms to patients that have a posterior annular bow that is displaced from the midline.
It is believed that most patients have such a malfornied anatomy resulting from the pathologic conditions described herein. However, posterior bows that are centered or even offset to the left have been observed. Therefore, one configuration of ring that is embodied in the present invention is one that is pre-shaped with a posterior bow in the middle or to the right, and that is malleable so that the bow can be exaggerated or d1n11111Shed by the surgeon after examination of the precise shape of the patient's annulus. Further, in such a convertible ring the bow can even be displaced, from the right to the left, for example. Although the material of the ring permits manual deformation, it would be stiff enough to withstand further deformation once implanted and subjected to normal physiologic stresses.
The ring preferably includes an inner ring body and an outer sewing sheath that permits the ring body to be sutured into the mural annulus. The sewing sheath should be sufficiently porous and/or flexible to pernit sutures to be passed therethrough. One exemplary construction is to enclose the inner ring body in a tubular sheath of suture-permeable material, such as silicone, which is then covered with a fabric hlbe, such as polyethyl terapthalate.
As opposed to t7exible annuloplasty rings that are designed simply to reduce the circumference of the mitral annulus, the annuloplasty ring of the present invention must be semi-rigid. It must retain its posterior bow in opposition to the stresses that will be imparted by muscles of the heart throughout each beating cycle. For example, the ring body may be made from materials such as Elgiloy (a cobalt-nickel alloy), titanium, or Nitinol (a nickel-titanium alloy).
Fig. 10 illustrates one exemplary construction of the inner body of the annuloplasty rings of the present invention that utilizes multiple flat bands of Elgiloy in a composite structure. Specifically, there are four bands 70a, 70b, 70c, and 70d from the outside to the inside. The four bands are concentrically disposed in the shape of the ring. Each band is a tlat strip of material having a width of between about 1.4-2.0 mm (O.OSG-0.078 inches). In one embodiment, the bands 70 overlap in the anterior section 72 of the ring body and are fastened together by, for example, spot welding at multiple points. The width of each strip may also be greater in the anterior section 72 than in a posterior section 74, which means that the ring body is more flexible in the posterior section than in any other section. Although not shown, a plurality of strips of protective film is used in between each band 70, and on the outer face of the outer band 70a. The strips may be a polymer such as Mylar. The strips help reduce rubbing between the bands 70 and also deflect suture needles fI'0111 the outer band 70a and thus prevent scratching thereto.
It will also be readily apparent that supporting the mural valve annulus with the present annuloplasty ring will maintain the posterior leaflet depressed below the anterior leaflet, and thus the area of coaptation therebetween will be different than in a healthy valve. This is required by the pathology of the ventricle with displacement of the papillary muscles and posterior leaflet.
However, those of skill in the art will recognize that this slight realignment of the leaflets is acceptable because of the surplus area of the leaflets available for coaptation, and because the realignment will be offset by other changes to the shape of the annulus that should over time improve coaptation of the two leaflets and therefore decrease regurgitation.
It will also be appreciated by those of skill in the relevant art that various modifications or changes may be made to the examples and embodiments of the invention described in this provisional application, without departing from the intended spirit and scope of the invention. In this regard, the particular embodiments of the invention described herein are to be understood as examples of the broader inventive concept disclosed in this application.
annuloplasty rings that follow the up-and-down shape of the three cusp aortic annulus. Such rings would not be suitable for cowecting a mitral valve deficiency.
While good results in the treatment of congestive heart failure and mural regurgitation have been obtained in the preliminary applications of the above-described methods and apparatuses, it is believed that these results can be significantly improved. Specifically, it would be desirable to produce a mitral annuloplasty ring that can reduce stresses associated with the implantation of conventional rings.
Summary of the Invention 5 The present invention provides an annuloplasty ring for implantation in a mural valve annulus that has a pathologic condition such that the posterior aspect thereof droops downward abnormally. The annuloplasty ring includes a rounded ring body having an anterior section and a posterior section. The ring body is oriented about a central flow axis that defines an upward direction and a downward direction, the downward direction corresponding to the direction of blood flow through the mural valve annulus. The posterior section the ring body bows downward out of a plane perpendicular to the central flow axis.
The ring body may bow downward between about 2-15 mm from one end thereof to a lowest point, and desirably bows downward between about 4-8 mm from one end thereof to a lowest point. The bow in the ring body may or may not be centered in the posterior section. Preferably, the ring body is made of a malleable material such that the bow in the ring body may be manually reshaped. Desirably, the ring body is made of a semi-rigid material that will retain its posterior bow in opposition to the stresses that will be imparted by muscles of the heart throughout each beating cycle. The ring body may be substantially planar except in the posterior section, or an anterior section of the ring body may bow upward from one end thereof to a lowest point.
In plan view, as seen along the flow axis, the ring body preferably defines an oval shape with a major axis perpendicular to a minor axis, the minor axis bisecting both the anterior and posterior sections. Further, the bow in the posterior section may begin at synnnetric locations across the minor axis that are spaced from the major axis around the ring body by an angle 0 of between about 0-45°, more preferably about 30°.
The ring body may further include two upward bows on either side of the downward bow on the posterior section, and wherein downward bow may G
be between about 2-15 mm. In one embodiment, the ring body comprises a plurality of ring elements concentrically disposed. A polymer strip in between each ring element may be provided. Optionally, the ring elements comprise bands that have a substantially larger height in the flow axis dimension than in the dimension perpendicular to the flow axis. Further, the ring elements may have varying heights so that. the ring body is more flexible in the posterior section than around the remainder of the ring body.
Another aspect of the present invention is a method of repairing a mural heart valve annulus that has a posterior aspect that is depressed downward along the blood flow axis relative to an anterior aspect. The method includes implanting an annuloplasty ring having an anterior section sized to fit the anterior aspect of the annulus and a posterior section sized to the posterior aspect, wherein the ring posterior section bows downward parallel to the central axis relative to the anterior section. The annuloplasty ring may be malleable and the surgeon adjusts the bow in the posterior section manually.
Another aspect of the invention is a method of repairing a mural heart valve annulus that has a posterior aspect, an anterior aspect, and a blood flow axis. The method includes inspecting the shape of the mural annulus and selecting a three-dimensional annuloplasty ring based on the shape of the mural annulus. The selected annuloplasty ring has an anterior section and a posterior section generally arranged around a central axis. The central axis defines an upward direction and a downward direction, wherein the ring posterior section bows downward out of a plane perpendicular to the central axis. The method includes implanting the annuloplasty ring so that the ring posterior section attaches to the posterior aspect of the mural valve annulus and the posterior section bows in the blood flow direction.
Brief Description of the Drawings Fig. 1 is a cross-section of a healthy left ventricle through the mural valve between the anterior and posterior leaflets;
Fig. 2 is a cross-section of a dilated left ventricle through the mural valve between the anterior and posterior leaflets;
Fig. 3 is an atrial view of the mural valve of Fig. 2 exposed during a surgical procedure;
Fig. 4 is a plan view of annuloplasty ring of the present invention implanted so as to restore competency to the mitral valve;
Fig. 5 is a perspective view of an annuloplasty ring of the present invention over an abnormal mural valve as viewed from the posterior side;
Fig. 6 is a perspective view of the annuloplasty ring of Fig. 5 over the abnormal mural valve as seen from the side;
Figs. 7A-7C are plan, front, and side views of an exemplary annuloplasty ring of the present invention having a posterior bow;
Figs. 8A-8C are plan, front, and side views of an alternative annuloplasty ring of the present invention having a posterior bow between two raised portions;
Figs 9A and 9B are front and side elevational views, respectively, of an inner ring body of a further annuloplasty ring of the present invention having an off center posterior bow and an anterior bow; and Fig. 10 is a top plan view of an inner ring body of an annuloplasty ring of the present invention showing details of a composite band construction.
DESCRIPTION OF THE PREFERRED EMBODIMENTS.
The attached figures illustrate several exemplary embodiments of the annuloplasty ring of the present invention, which can be described as being continuous and having an anterior side, a posterior side and right and left sides.
All of the sides are generally curvilinear with no specific demarcations to indicate abrupt transitions therebetween. Rather, smooth transitional sections between the adjacent sides provide curvilinear connections that give the ring a generally rounded (e.g., oval) configuration.
An exemplary annuloplasty ring 30 of the present invention is shown in Fig. 4 implanted around a mural annulus MA. As described above, the mural annulus has an anterior leaflet AL and a posterior leaflet PL. When the ring is implanted, the leaflets are brought closer together and supported so that they meet at a coaptation surface 32. The ring 30 thus corrects the problem of functional mural regurgitation.
The ring 30 has an oval or somewhat D-shaped configuration with a relatively straight anterior section 34 opposite a curved posterior section 36. A
pair of trigone or commissure markers 38a, 38b generally delimit the anterior side 34, while a pair of opposed side sections 40a, 40b extend between each of these markers and the posterior section 36. A plurality of knotted suture loops 42 are typically used to secure the ring 30 to the mitral annulus MA, although other fasteners such as staples, fibrin glue, or the like may be used.
In the pathological conditions for which the annuloplasty ring 30 is best suited, the posterior aspect of the mural annulus is depressed relative to the anterior aspect, as is illustrated in Fig. 2. In the view of Fig. 4, the posterior aspect will be depressed into the page relative to the anterior aspect. The annuloplasty ring 30 of the present invention has a shaped posterior section that generally follows the modified shape of the mural annulus MA. In other words, the posterior section 36 is bowed into the page relative to the anterior section 34. When secured in place with sutures 42, for example, the ring 30 supports the mitral annulus MA in its modified shape, rather than trying to revert the annulus back to the original substantially planar configuration. At the same time, the ring 30 desirably constricts the orifice circumference defined by the annulus so as to bring the anterior leaflet AL and posterior leaflet PL
closer together. Because the ring 30 does not pull the posterior aspect of the mural annulus MA upward from its modified position, high stresses are not set up in the attachment sutures 42 and thus there is less potential for the dehiscence.
Figs. S and 6 illustrate the exemplary annuloplasty ring 30 in perspective above a mural annulus that is depressed on its posterior side. The bow of the ring 30 in its posterior section 36 is seen best in Fig. 6 mimicking the depression of the posterior aspect of the mural annulus MA in the pathology encountered with functional mitral regurgitation.
The exemplary annuloplasty ring 30 of Figs. 4-6 is shown in more detail in Figs. 7A-7C. The ring 30 is shown complete with a fabric covering. For purpose of orientation, Fig. 7A illustrates orthogonal axes wherein the X- and Y-axes generally define the datum plane 20 as mentioned above with respect to Figs. 1 and 2. The X-axis extends across the ring 30 from one side 40a to the opposite side 40b at the point of maximum dimension. The X-axis thus defines a major axis of the ring 30. The Y-axis defines a plane of symmetry for the ring 30 extending between a midpoint of the anterior side 34 to a midpoint of the posterior section 3G. The Y-axis also defines a minor axis for the ring 30.
As with many conventional rings, the ratio of the minor axis dimension to the major axis dimension is desirably about 3:4. This size ratio is the "classic" shape of the mural annulus, and may be the best configuration of the annuloplasty ring 30. However, it is contemplated that other shapes that have smaller minor axis-to-major axis ratios may actually increase leaflet coaptation.
Although not geometrically precise, the non-circular ring configuration may be considered oval, elliptical or D-shaped. It should be noted that the present invention could also take the form of a discontinuous ring that has a C-shape, for example. The break in such a ring may be in the anterior section, and the posterior section is continuous and exhibits the downward bow as explained.
The Z-axis in Fig. 7B lies along of the axis of blood flow through the ring 30 when implanted, and it will be understood that the positive Z
direction is the "upward" direction, the negative Z direction is the "downward" direction, and the ring 30 is designed to be implanted in a mural annulus such that blood will flow in the downward direction.
Several points are noted around the ring 30 to help describe the posterior bow. These points, and the ones shown in Figs. 8A-8B, are imaginary center points through the cross-section of the ring 30. Two points A are symmetrically located on either side of the Y-axis at an angular distance 0 from the X-axis.
The midpoint of the posterior section 3G is denoted B. The ring 30 has a posterior bow such that the point B is at the lowest elevation along the Z-axis.
The magnitude of this posterior bow is indicated by the dimension Z, in Fig.
5 7C. The points A on either side of the posterior section 3G represent the location where the posterior bow begins. That is, except for the posterior section, the ring 30 is preferably substantially planar. However, the anterior section 34 can optionally be bowed upward by a distance of between about 2-4 mm (0.08-0.1 G inches), as in certain rings of the prior art. In the latter example, 10 the posterior section 36 bows downward in the Z-direction relative to the elevation of the trigone markers 38a, 38b.
Various possible configurations for the ring 30 as seen in Figs. 7A-7C
are contemplated, with the dimension Z, and the angle 8 varying between ranges determined by the overall size of the mural annulus, the extent of anatomical droop of the posterior aspect, and various other factors including surgeon preference. Nevertheless, certain ranges are believed suitable to support and correct a majority of the patients exhibiting the particular anatomical irregularity as described herein. The downward bow or posterior bow preferably extends along a majority of the posterior section 3G between the points A, which points are between 0 and 45° from the X-axis (0). More preferably, the points A are between 20-40°, and more particularly about 30°
from the X-axis. The magnitude of bow Z, may be between about 2-15 mm (0.08-0.59 inches), and more typically is between about 4-8 mm (0.1 G-0.31 inches), depending on the size of the ring.
Although the ring 30 is shown in Figs. 7A-7C as symmetric about the Y-axis, it does not necessarily have to be so. For example, the point B may be displaced from the Y-axis such that the downward bow is not centered in the posterior section 3G. An asymmetric ring is shown and described below with reference to Figs. 9A and 9B.
Figs. 8A-8C illustrate an alternative annuloplasty ring 50 of the present invention that has both upward and downward bows. Again, the ring 50 is shown complete with a fabric covering. The ring 50 includes an anterior section 52, a posterior section 54, and a pair of side sections (not numbered) therebetween. The ring 50 is generally planar on the anterior section 52 and shaped on the posterior section 54. The points A symmetrically disposed across the Y-axis again denote the locations on each side where the ring 50 begins to curve out of a plane. In this embodiment, the ring curves upward in the Z-direction from the points A, as best seen in Fig. 8B, to high points C, and then dips downward to the midpoint B of the posterior section 54. The downward bow of the ring between points A and Q is shown in Fig. 8C as the dimension Zz, which has a magnitude similar to that given for Z, in Fig. 7C. The upward curve may be selected so as to better match the patient's annulus shape.
Furthermore, the anterior section 52 may be upwardly bowed by a distance of between about 2-4 mm (0.08-0.16 inches).
Various permutations of the ring 50 shown in Figs. 8A-8C are contemplated, with the dimensions being altered based on numerous factors. In an exemplary embodiment, the points A are desirably disposed an angular distance oc from the X-axis of between about 0-15°, and more desirably between about 5-10". The points C of 111aXlllll1111 height of the ring 50 are preferably spaced an angular distance [3 from the X-axis of between about 15-45", and more preferably between about 25-35°. The lowest point B of the ring 50 may be bowed along the Z-axis as in the embodiment of Figs. 7A-7C, so that, as indicated Fig. 8C, Zz is desirably between about 2-15 171111 (0.08-0.59 inches), and more typically is between about 4-8 171111 (0.16-0.31 inches), depending on the size of the ring. Therefore, the total height of the ring 50 is at least 2 mm, and may be greater than 15 mm.
Figs. 9A and 9B show an inner ring body 60 for use in an annuloplasty ring of the present invention. The ring body 60 has a posterior bow 62 that is offset from the center of a posterior section 64. In the illustrated embodiment, the bow 62 is offset toward the posterio-medial side (to the right) by about 20%
of the entire major axis width of the ring body 60. Another way to state the offset is that, in plan view, the bow G2 is centered at a clock position, with 12:00 being centered in the anterior side. In that sense, the bow 62 is centered between 3:00 and 6:00, and more preferably is centered at about 5:00. The axial bow Z3 is shown and may vary from about 2.0 mm (0.08 inches) to about 4.0 mm (0.1 G inches), and more preferably from about 3.0 mm (0.12 inches) to about 3.8 mm (0.15 inches), depending on ring size. In addition, the ring body 60 has an anterior section 6G that is upwardly bowed by a distance of between about 2-4 mm (0.08-0.1 G inches).
The inner ring body 60 demonstrates an asymmetric ring that conforms to patients that have a posterior annular bow that is displaced from the midline.
It is believed that most patients have such a malfornied anatomy resulting from the pathologic conditions described herein. However, posterior bows that are centered or even offset to the left have been observed. Therefore, one configuration of ring that is embodied in the present invention is one that is pre-shaped with a posterior bow in the middle or to the right, and that is malleable so that the bow can be exaggerated or d1n11111Shed by the surgeon after examination of the precise shape of the patient's annulus. Further, in such a convertible ring the bow can even be displaced, from the right to the left, for example. Although the material of the ring permits manual deformation, it would be stiff enough to withstand further deformation once implanted and subjected to normal physiologic stresses.
The ring preferably includes an inner ring body and an outer sewing sheath that permits the ring body to be sutured into the mural annulus. The sewing sheath should be sufficiently porous and/or flexible to pernit sutures to be passed therethrough. One exemplary construction is to enclose the inner ring body in a tubular sheath of suture-permeable material, such as silicone, which is then covered with a fabric hlbe, such as polyethyl terapthalate.
As opposed to t7exible annuloplasty rings that are designed simply to reduce the circumference of the mitral annulus, the annuloplasty ring of the present invention must be semi-rigid. It must retain its posterior bow in opposition to the stresses that will be imparted by muscles of the heart throughout each beating cycle. For example, the ring body may be made from materials such as Elgiloy (a cobalt-nickel alloy), titanium, or Nitinol (a nickel-titanium alloy).
Fig. 10 illustrates one exemplary construction of the inner body of the annuloplasty rings of the present invention that utilizes multiple flat bands of Elgiloy in a composite structure. Specifically, there are four bands 70a, 70b, 70c, and 70d from the outside to the inside. The four bands are concentrically disposed in the shape of the ring. Each band is a tlat strip of material having a width of between about 1.4-2.0 mm (O.OSG-0.078 inches). In one embodiment, the bands 70 overlap in the anterior section 72 of the ring body and are fastened together by, for example, spot welding at multiple points. The width of each strip may also be greater in the anterior section 72 than in a posterior section 74, which means that the ring body is more flexible in the posterior section than in any other section. Although not shown, a plurality of strips of protective film is used in between each band 70, and on the outer face of the outer band 70a. The strips may be a polymer such as Mylar. The strips help reduce rubbing between the bands 70 and also deflect suture needles fI'0111 the outer band 70a and thus prevent scratching thereto.
It will also be readily apparent that supporting the mural valve annulus with the present annuloplasty ring will maintain the posterior leaflet depressed below the anterior leaflet, and thus the area of coaptation therebetween will be different than in a healthy valve. This is required by the pathology of the ventricle with displacement of the papillary muscles and posterior leaflet.
However, those of skill in the art will recognize that this slight realignment of the leaflets is acceptable because of the surplus area of the leaflets available for coaptation, and because the realignment will be offset by other changes to the shape of the annulus that should over time improve coaptation of the two leaflets and therefore decrease regurgitation.
It will also be appreciated by those of skill in the relevant art that various modifications or changes may be made to the examples and embodiments of the invention described in this provisional application, without departing from the intended spirit and scope of the invention. In this regard, the particular embodiments of the invention described herein are to be understood as examples of the broader inventive concept disclosed in this application.
Claims (23)
1. An annuloplasty ring for implantation in a mitral valve annulus, said annuloplasty ring comprising:
a rounded ring body having an anterior section adapted to be implanted on the anterior aspect of the mitral valve annulus, and a posterior section adapted to be implanted on the posterior aspect of the mitral valve annulus;
wherein the ring body is oriented about a central flow axis, the flow axis defining an upward direction and a downward direction, the downward direction corresponding to the direction of blood flow through the mitral valve annulus;
and, wherein in the posterior section the ring body bows downward out of a plane perpendicular to the central flow axis, and wherein the downward bow is off-center in the posterior section and exhibits smooth curvilinear transitions to the adjacent ring body sections.
a rounded ring body having an anterior section adapted to be implanted on the anterior aspect of the mitral valve annulus, and a posterior section adapted to be implanted on the posterior aspect of the mitral valve annulus;
wherein the ring body is oriented about a central flow axis, the flow axis defining an upward direction and a downward direction, the downward direction corresponding to the direction of blood flow through the mitral valve annulus;
and, wherein in the posterior section the ring body bows downward out of a plane perpendicular to the central flow axis, and wherein the downward bow is off-center in the posterior section and exhibits smooth curvilinear transitions to the adjacent ring body sections.
2. The annuloplasty ring of claim 1, wherein, in the posterior section, the ring body bows downward between about 2-15 mm as measured along the flow axis from a point around the ring body at which the downward bow begins to a lowest point of the downward bow.
3. The annuloplasty ring of claim 2, wherein the ring body bows downward between about 4-8 mm.
4. The annuloplasty ring of claim 1, wherein the bow in the ring body is off-center in the posterior section toward a posterio-medial side of the ring body as viewed from an inflow perspective.
5. The annuloplasty ring of claim 4, wherein in plan view as seen along the flow axis the ring body generally defines an oval shape with a major axis perpendicular to a minor axis, wherein the minor axis bisects both the anterior and posterior sections, and wherein the bow in the posterior section is offset toward the posterio-medial side by about 20% of the entire major axis width of the ring body.
6. The annuloplasty ring of claim 4, wherein in plan view as seen along the flow axis the ring body generally defines an oval shape with a major axis perpendicular to a minor axis, wherein the minor axis bisects both the anterior and posterior sections, and wherein the bow in the posterior section is centered at a clock position, with 12:00 being centered in the anterior side, and the bow is centered between 3:00 and 6:00.
7. The annuloplasty ring of claim 1, wherein the ring body is made of a malleable material such that the bow in the ring body may be manually reshaped.
8. The annuloplasty ring of claim 1, wherein the ring body is made or a semi-rigid material that will retain its posterior bow in opposition to the stresses that will be imparted by muscles of the heart throughout each beating cycle.
9. The annuloplasty ring of claim 1, wherein in the anterior section the ring body bows upward from adjacent trigone markers.
10. The annuloplasty ring of claim 1, wherein the ring body comprises a plurality of ring elements concentrically disposed.
11. The annuloplasty ring of claim 10, further including a polymer strip in between each ring element.
12. The annuloplasty ring of claim 10, wherein the ring elements comprise bands that have a substantially larger height in the flow axis dimension than in the dimension perpendicular to the flow axis.
13. The annuloplasty ring of claim 12, wherein the ring elements have varying heights so that the ring body is more flexible in the posterior section than around the remainder of the ring body.
14. Use of an annuloplasty ring for repairing a mitral heart valve annulus that has a posterior aspect that is depressed downward along the blood flow axis relative to an anterior aspect, said annuloplasty ring having an anterior section sized to fit the anterior aspect of the annulus and a posterior section sized to the posterior aspect, wherein the ring posterior section bows downward parallel to the central axis relative to the anterior section.
15. The use of an annuloplasty ring of claim 14, wherein the annuloplasty ring is malleable and the surgeon adjusts the bow in the posterior section manually.
16. The use of an annuloplasty ring of claim 14, wherein the ring posterior section bows downward between about 4-8 mm parallel to the central axis relative to the anterior section.
17. The use of an annuloplasty ring of claim 14, wherein the posterior aspect is depressed downward along the blood flow axis off-center in the posterior section and the bow in the ring is similarly off-center in the posterior section.
18. The use of an annuloplasty ring of claim 17, wherein the posterior aspect is depressed downward along the blood flow axis toward a posterio-medial side of the mitral annulus and the bow in the ring is similarly off-center in the posterior section toward a posterio-medial side of the ring.
19. The use of an annuloplasty ring of claim 14, wherein the ring body is made of a malleable material and the method includes manually reshaping the ring to have the posterior bow.
20. The use of a three-dimensional annuloplasty ring for repairing a mitral heart valve annulus that has a downwardly depressed posterior aspect, an anterior aspect, and a blood flow axis, said annuloplasty ring being selected based on the shape of the mitral annulus, the annuloplasty ring having an anterior section and a posterior section generally arranged around a central axis, the central axis defining an upward direction and a downward direction, wherein the ring posterior section bows downward out of a plane perpendicular to the central axis; and said annuloplasty ring is implanted so that the ring posterior section attaches to the posterior aspect of the mitral valve annulus and the posterior section bows in the blood flow direction.
21. An annuloplasty ring for implantation in a mitral valve annulus, said annuloplasty ring comprising:
a rounded ring body having an anterior section adapted to be implanted on the anterior aspect of the mitral valve annulus and a posterior section adapted to be implanted on the posterior aspect of the mitral valve annulus;
wherein the ring body is oriented about a central flow axis, the flow axis defining an upward direction and a downward direction, the downward direction corresponding to the direction of blood flow through the mitral valve annulus wherein the ring body comprises a plurality of bands concentrically disposed that have a substantially larger height in the flow axis dimension than in the dimension perpendicular to the flow axis, and wherein the bands have varying heights so that the ring body is more flexible in the posterior section than around the remainder of the ring body; and, wherein in the posterior section the ring body bows downward out of a plane perpendicular to the central flow axis.
a rounded ring body having an anterior section adapted to be implanted on the anterior aspect of the mitral valve annulus and a posterior section adapted to be implanted on the posterior aspect of the mitral valve annulus;
wherein the ring body is oriented about a central flow axis, the flow axis defining an upward direction and a downward direction, the downward direction corresponding to the direction of blood flow through the mitral valve annulus wherein the ring body comprises a plurality of bands concentrically disposed that have a substantially larger height in the flow axis dimension than in the dimension perpendicular to the flow axis, and wherein the bands have varying heights so that the ring body is more flexible in the posterior section than around the remainder of the ring body; and, wherein in the posterior section the ring body bows downward out of a plane perpendicular to the central flow axis.
22. The annuloplasty ring of claim 21, further including a polymer strip in between each ring element.
23. The annuloplasty ring of claim 21, wherein the bands overlap in the anterior section of the ring body and are fastened together at multiple points.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/192,516 US6858039B2 (en) | 2002-07-08 | 2002-07-08 | Mitral valve annuloplasty ring having a posterior bow |
| US10/192,516 | 2002-07-08 | ||
| PCT/US2003/021208 WO2004004607A1 (en) | 2002-07-08 | 2003-07-03 | Mitral valve annuloplasty ring having a posterior bow |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2489368A1 CA2489368A1 (en) | 2004-01-15 |
| CA2489368C true CA2489368C (en) | 2011-08-23 |
Family
ID=30000029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2489368A Expired - Lifetime CA2489368C (en) | 2002-07-08 | 2003-07-03 | Mitral valve annuloplasty ring having a posterior bow |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6858039B2 (en) |
| EP (1) | EP1519695B1 (en) |
| JP (1) | JP4384978B2 (en) |
| AT (1) | ATE339934T1 (en) |
| AU (1) | AU2003248833B2 (en) |
| BR (1) | BR0312502B1 (en) |
| CA (1) | CA2489368C (en) |
| DE (1) | DE60308523T2 (en) |
| WO (1) | WO2004004607A1 (en) |
Families Citing this family (240)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406420B1 (en) * | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
| FR2768324B1 (en) | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
| US6332893B1 (en) * | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
| US6736845B2 (en) * | 1999-01-26 | 2004-05-18 | Edwards Lifesciences Corporation | Holder for flexible heart valve |
| EP2078498B1 (en) | 1999-04-09 | 2010-12-22 | Evalve, Inc. | Apparatus for cardiac valve repair |
| US6752813B2 (en) | 1999-04-09 | 2004-06-22 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
| US7226467B2 (en) | 1999-04-09 | 2007-06-05 | Evalve, Inc. | Fixation device delivery catheter, systems and methods of use |
| US10327743B2 (en) | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
| US6440164B1 (en) * | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
| US7011682B2 (en) * | 2000-01-31 | 2006-03-14 | Edwards Lifesciences Ag | Methods and apparatus for remodeling an extravascular tissue structure |
| US6537198B1 (en) * | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
| US7510572B2 (en) * | 2000-09-12 | 2009-03-31 | Shlomo Gabbay | Implantation system for delivery of a heart valve prosthesis |
| US6616684B1 (en) * | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
| US6723038B1 (en) * | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
| US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
| US6786924B2 (en) * | 2001-03-15 | 2004-09-07 | Medtronic, Inc. | Annuloplasty band and method |
| US6955689B2 (en) * | 2001-03-15 | 2005-10-18 | Medtronic, Inc. | Annuloplasty band and method |
| ITMI20011012A1 (en) * | 2001-05-17 | 2002-11-17 | Ottavio Alfieri | ANNULAR PROSTHESIS FOR MITRAL VALVE |
| US7935145B2 (en) | 2001-05-17 | 2011-05-03 | Edwards Lifesciences Corporation | Annuloplasty ring for ischemic mitral valve insuffuciency |
| US6908482B2 (en) | 2001-08-28 | 2005-06-21 | Edwards Lifesciences Corporation | Three-dimensional annuloplasty ring and template |
| US7367991B2 (en) * | 2001-08-28 | 2008-05-06 | Edwards Lifesciences Corporation | Conformal tricuspid annuloplasty ring and template |
| US20080154359A1 (en) * | 2001-11-01 | 2008-06-26 | Salgo Ivan S | Non-planar cardiac vascular support prosthesis |
| US6805710B2 (en) * | 2001-11-13 | 2004-10-19 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring for molding left ventricle geometry |
| US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
| US6764510B2 (en) * | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
| US7118595B2 (en) * | 2002-03-18 | 2006-10-10 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
| US6719786B2 (en) * | 2002-03-18 | 2004-04-13 | Medtronic, Inc. | Flexible annuloplasty prosthesis and holder |
| US6752828B2 (en) | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
| US7007698B2 (en) * | 2002-04-03 | 2006-03-07 | Boston Scientific Corporation | Body lumen closure |
| US20030233022A1 (en) * | 2002-06-12 | 2003-12-18 | Vidlund Robert M. | Devices and methods for heart valve treatment |
| US7608103B2 (en) * | 2002-07-08 | 2009-10-27 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring having a posterior bow |
| AU2003285943B2 (en) * | 2002-10-24 | 2008-08-21 | Boston Scientific Limited | Venous valve apparatus and method |
| US7247134B2 (en) * | 2002-11-12 | 2007-07-24 | Myocor, Inc. | Devices and methods for heart valve treatment |
| US7112219B2 (en) * | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
| US6945957B2 (en) * | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
| DE10301023A1 (en) * | 2003-01-13 | 2004-07-22 | Medos Medizintechnik Ag | Implant, in particular ring for heart valve, designed in curved and asymmetric shape |
| KR100466839B1 (en) * | 2003-03-28 | 2005-01-17 | 주식회사 사이언씨티 | Aortic valve Repairing Apparatus Sets and Treatment Method Using The Same |
| US10667823B2 (en) | 2003-05-19 | 2020-06-02 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
| US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
| US7854761B2 (en) * | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
| US7871435B2 (en) * | 2004-01-23 | 2011-01-18 | Edwards Lifesciences Corporation | Anatomically approximate prosthetic mitral heart valve |
| EP1943982A1 (en) * | 2004-02-23 | 2008-07-16 | International Heart Institute of Montana Foundation | Papilloplasty band and sizing device |
| US8206439B2 (en) * | 2004-02-23 | 2012-06-26 | International Heart Institute Of Montana Foundation | Internal prosthesis for reconstruction of cardiac geometry |
| US20090132035A1 (en) * | 2004-02-27 | 2009-05-21 | Roth Alex T | Prosthetic Heart Valves, Support Structures and Systems and Methods for Implanting the Same |
| US20070073387A1 (en) * | 2004-02-27 | 2007-03-29 | Forster David C | Prosthetic Heart Valves, Support Structures And Systems And Methods For Implanting The Same |
| US8430925B2 (en) * | 2004-02-27 | 2013-04-30 | Cardiacmd, Inc. | Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same |
| US7951196B2 (en) | 2004-04-29 | 2011-05-31 | Edwards Lifesciences Corporation | Annuloplasty ring for mitral valve prolapse |
| US7294148B2 (en) | 2004-04-29 | 2007-11-13 | Edwards Lifesciences Corporation | Annuloplasty ring for mitral valve prolapse |
| US7938856B2 (en) * | 2004-05-14 | 2011-05-10 | St. Jude Medical, Inc. | Heart valve annuloplasty prosthesis sewing cuffs and methods of making same |
| US7452376B2 (en) * | 2004-05-14 | 2008-11-18 | St. Jude Medical, Inc. | Flexible, non-planar annuloplasty rings |
| ES2436399T3 (en) * | 2004-05-14 | 2013-12-30 | St. Jude Medical, Inc. | Apparatus for holding and supporting an annuloplasty ring |
| US20050278022A1 (en) * | 2004-06-14 | 2005-12-15 | St. Jude Medical, Inc. | Annuloplasty prostheses with improved anchoring structures, and related methods |
| EP1629795B1 (en) * | 2004-06-29 | 2008-01-16 | SIEVERS, Hans-Hinrich, Dr. | Annuloplasty Ring |
| US7758638B2 (en) * | 2004-07-13 | 2010-07-20 | Ats Medical, Inc. | Implant with an annular base |
| US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
| US8052592B2 (en) | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
| EP1793745B2 (en) | 2004-09-27 | 2022-03-16 | Evalve, Inc. | Devices for tissue grasping and assessment |
| BRPI0404380C1 (en) * | 2004-10-14 | 2008-07-15 | Malavazi Vedacoes Ind Ltda | housed mechanical seal enhancements for progressive cavity pumps |
| US7854755B2 (en) * | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
| US20060173490A1 (en) | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
| US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
| US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
| WO2006086434A1 (en) | 2005-02-07 | 2006-08-17 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
| WO2011034628A1 (en) | 2005-02-07 | 2011-03-24 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
| US7670368B2 (en) * | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
| US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
| WO2006097931A2 (en) | 2005-03-17 | 2006-09-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
| US7842085B2 (en) * | 2005-03-23 | 2010-11-30 | Vaso Adzich | Annuloplasty ring and holder combination |
| US7575595B2 (en) | 2005-03-23 | 2009-08-18 | Edwards Lifesciences Corporation | Annuloplasty ring and holder combination |
| US7722666B2 (en) * | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
| US20060247491A1 (en) * | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for heart valve treatment |
| US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
| US8685083B2 (en) * | 2005-06-27 | 2014-04-01 | Edwards Lifesciences Corporation | Apparatus, system, and method for treatment of posterior leaflet prolapse |
| WO2007002320A1 (en) * | 2005-06-27 | 2007-01-04 | The Cleveland Clinic Foundation | Apparatus for placement in the annulus of a tricuspid valve |
| US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
| US7682391B2 (en) * | 2005-07-13 | 2010-03-23 | Edwards Lifesciences Corporation | Methods of implanting a prosthetic mitral heart valve having a contoured sewing ring |
| US7455689B2 (en) * | 2005-08-25 | 2008-11-25 | Edwards Lifesciences Corporation | Four-leaflet stented mitral heart valve |
| US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
| US9011528B2 (en) * | 2005-09-30 | 2015-04-21 | Medtronic, Inc. | Flexible annuloplasty prosthesis |
| US8048152B2 (en) * | 2005-09-30 | 2011-11-01 | Medtronic, Inc. | Method of implanting an annuloplasty prosthesis |
| WO2007050506A1 (en) | 2005-10-26 | 2007-05-03 | St. Jude Medical, Inc. | Saddle-shaped mitral valve annuloplasty prostheses with asymmetry, and related methods |
| US8764820B2 (en) | 2005-11-16 | 2014-07-01 | Edwards Lifesciences Corporation | Transapical heart valve delivery system and method |
| US10039531B2 (en) | 2005-12-15 | 2018-08-07 | Georgia Tech Research Corporation | Systems and methods to control the dimension of a heart valve |
| WO2007100410A2 (en) | 2005-12-15 | 2007-09-07 | Georgia Tech Research Corporation | Systems and methods for enabling heart valve replacement |
| JP5371440B2 (en) | 2005-12-15 | 2013-12-18 | ジョージア テック リサーチ コーポレイション | Papillary muscle position control device, system and method |
| US7799038B2 (en) * | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
| US8147541B2 (en) * | 2006-02-27 | 2012-04-03 | Aortx, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
| US8403981B2 (en) * | 2006-02-27 | 2013-03-26 | CardiacMC, Inc. | Methods and devices for delivery of prosthetic heart valves and other prosthetics |
| EP2029053B1 (en) * | 2006-05-15 | 2011-02-23 | Edwards Lifesciences AG | A system for altering the geometry of the heart |
| US8585594B2 (en) * | 2006-05-24 | 2013-11-19 | Phoenix Biomedical, Inc. | Methods of assessing inner surfaces of body lumens or organs |
| JP2009539422A (en) * | 2006-06-02 | 2009-11-19 | メドトロニック・インコーポレーテッド | Annuloplasty ring and plastic surgery |
| WO2007143049A1 (en) | 2006-06-02 | 2007-12-13 | Medtronic, Inc. | Annuloplasty prosthesis with in vivo shape identification and related methods of use |
| AU2007261016A1 (en) * | 2006-06-20 | 2007-12-27 | Aortx, Inc. | Prosthetic valve implant site preparation techniques |
| CN101506538A (en) * | 2006-06-20 | 2009-08-12 | 奥尔特克斯公司 | Torque shaft and torque drive |
| US8500799B2 (en) * | 2006-06-20 | 2013-08-06 | Cardiacmd, Inc. | Prosthetic heart valves, support structures and systems and methods for implanting same |
| CA2657446A1 (en) * | 2006-06-21 | 2007-12-27 | Aortx, Inc. | Prosthetic valve implantation systems |
| US20080058924A1 (en) * | 2006-09-01 | 2008-03-06 | Aaron Ingle | Saddle-shaped annuloplasty ring |
| US20100256752A1 (en) * | 2006-09-06 | 2010-10-07 | Forster David C | Prosthetic heart valves, support structures and systems and methods for implanting the same, |
| US8163011B2 (en) | 2006-10-06 | 2012-04-24 | BioStable Science & Engineering, Inc. | Intra-annular mounting frame for aortic valve repair |
| US7879087B2 (en) * | 2006-10-06 | 2011-02-01 | Edwards Lifesciences Corporation | Mitral and tricuspid annuloplasty rings |
| US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
| US9883943B2 (en) | 2006-12-05 | 2018-02-06 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
| US8926695B2 (en) | 2006-12-05 | 2015-01-06 | Valtech Cardio, Ltd. | Segmented ring placement |
| WO2008091493A1 (en) | 2007-01-08 | 2008-07-31 | California Institute Of Technology | In-situ formation of a valve |
| EP3488822B1 (en) * | 2007-01-26 | 2020-10-21 | Medtronic, Inc. | Annuloplasty device for tricuspid valve repair |
| US9381084B2 (en) | 2007-01-26 | 2016-07-05 | Medtronic, Inc. | Annuloplasty device for tricuspid valve repair |
| WO2008097589A1 (en) | 2007-02-05 | 2008-08-14 | Boston Scientific Limited | Percutaneous valve, system, and method |
| US20080269877A1 (en) * | 2007-02-05 | 2008-10-30 | Jenson Mark L | Systems and methods for valve delivery |
| US20090157176A1 (en) * | 2007-02-09 | 2009-06-18 | Alain Carpentier | Annuloplasty rings for correcting degenerative valvular diseases |
| US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
| US8529620B2 (en) * | 2007-05-01 | 2013-09-10 | Ottavio Alfieri | Inwardly-bowed tricuspid annuloplasty ring |
| US8828079B2 (en) * | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
| CN103393485B (en) | 2007-09-07 | 2016-08-10 | 爱德华兹生命科学公司 | For carrying the travel(l)ing rest of annuloplasty ring |
| US8784483B2 (en) | 2007-11-19 | 2014-07-22 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
| US8216303B2 (en) * | 2007-11-19 | 2012-07-10 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
| US7892276B2 (en) * | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
| US20090171456A1 (en) * | 2007-12-28 | 2009-07-02 | Kveen Graig L | Percutaneous heart valve, system, and method |
| US7993395B2 (en) * | 2008-01-25 | 2011-08-09 | Medtronic, Inc. | Set of annuloplasty devices with varying anterior-posterior ratios and related methods |
| US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
| US8152844B2 (en) | 2008-05-09 | 2012-04-10 | Edwards Lifesciences Corporation | Quick-release annuloplasty ring holder |
| US20090287303A1 (en) * | 2008-05-13 | 2009-11-19 | Edwards Lifesciences Corporation | Physiologically harmonized tricuspid annuloplasty ring |
| US9192472B2 (en) | 2008-06-16 | 2015-11-24 | Valtec Cardio, Ltd. | Annuloplasty devices and methods of delivery therefor |
| US8287591B2 (en) * | 2008-09-19 | 2012-10-16 | Edwards Lifesciences Corporation | Transformable annuloplasty ring configured to receive a percutaneous prosthetic heart valve implantation |
| US9314335B2 (en) | 2008-09-19 | 2016-04-19 | Edwards Lifesciences Corporation | Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation |
| US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
| US8940044B2 (en) | 2011-06-23 | 2015-01-27 | Valtech Cardio, Ltd. | Closure element for use with an annuloplasty structure |
| WO2010073246A2 (en) | 2008-12-22 | 2010-07-01 | Valtech Cardio, Ltd. | Adjustable annuloplasty devices and adjustment mechanisms therefor |
| US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
| US8147542B2 (en) | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
| US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
| US8241351B2 (en) * | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
| US8808368B2 (en) | 2008-12-22 | 2014-08-19 | Valtech Cardio, Ltd. | Implantation of repair chords in the heart |
| US8926697B2 (en) | 2011-06-23 | 2015-01-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
| US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
| US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
| US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
| US8523881B2 (en) | 2010-07-26 | 2013-09-03 | Valtech Cardio, Ltd. | Multiple anchor delivery tool |
| US8439970B2 (en) * | 2009-07-14 | 2013-05-14 | Edwards Lifesciences Corporation | Transapical delivery system for heart valves |
| EP2477555B1 (en) | 2009-09-15 | 2013-12-25 | Evalve, Inc. | Device for cardiac valve repair |
| US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
| US8940042B2 (en) | 2009-10-29 | 2015-01-27 | Valtech Cardio, Ltd. | Apparatus for guide-wire based advancement of a rotation assembly |
| US8277502B2 (en) * | 2009-10-29 | 2012-10-02 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
| US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
| US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
| WO2011067770A1 (en) | 2009-12-02 | 2011-06-09 | Valtech Cardio, Ltd. | Delivery tool for implantation of spool assembly coupled to a helical anchor |
| US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
| US20110160849A1 (en) * | 2009-12-22 | 2011-06-30 | Edwards Lifesciences Corporation | Bimodal tricuspid annuloplasty ring |
| US8449608B2 (en) * | 2010-01-22 | 2013-05-28 | Edwards Lifesciences Corporation | Tricuspid ring |
| US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
| US8790394B2 (en) | 2010-05-24 | 2014-07-29 | Valtech Cardio, Ltd. | Adjustable artificial chordeae tendineae with suture loops |
| US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
| CA2808885C (en) | 2010-08-24 | 2017-01-10 | John F. Migliazza | Flexible annuloplasty ring with select control points |
| WO2012030370A1 (en) | 2010-08-31 | 2012-03-08 | Edwards Lifesciences Corporation | Physiologic tricuspid annuloplasty ring |
| ES2659542T3 (en) * | 2010-09-30 | 2018-03-16 | Biostable Science & Engineering Inc. | Intra-annular mounting frame for aortic valve repair |
| US9161835B2 (en) | 2010-09-30 | 2015-10-20 | BioStable Science & Engineering, Inc. | Non-axisymmetric aortic valve devices |
| US8932350B2 (en) | 2010-11-30 | 2015-01-13 | Edwards Lifesciences Corporation | Reduced dehiscence annuloplasty ring |
| US9381082B2 (en) | 2011-04-22 | 2016-07-05 | Edwards Lifesciences Corporation | Devices, systems and methods for accurate positioning of a prosthetic valve |
| US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
| US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
| US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
| US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
| US8945177B2 (en) | 2011-09-13 | 2015-02-03 | Abbott Cardiovascular Systems Inc. | Gripper pusher mechanism for tissue apposition systems |
| US8920493B2 (en) | 2011-09-16 | 2014-12-30 | St. Jude Medical, Cardiology Division, Inc. | Systems and methods for holding annuloplasty rings |
| US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
| EP3656434B1 (en) | 2011-11-08 | 2021-10-20 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
| US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
| CN102824231B (en) * | 2012-09-19 | 2015-03-11 | 马增山 | Mechanical suture type artificial heart valve and suture method thereof |
| WO2014052818A1 (en) | 2012-09-29 | 2014-04-03 | Mitralign, Inc. | Plication lock delivery system and method of use thereof |
| EP3730084A1 (en) | 2012-10-23 | 2020-10-28 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
| WO2014064695A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
| WO2014087402A1 (en) | 2012-12-06 | 2014-06-12 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
| US10543085B2 (en) | 2012-12-31 | 2020-01-28 | Edwards Lifesciences Corporation | One-piece heart valve stents adapted for post-implant expansion |
| CN104884001B (en) | 2012-12-31 | 2018-06-22 | 爱德华兹生命科学公司 | Expansible Surgical heart valve construction after implantation |
| US20150351906A1 (en) | 2013-01-24 | 2015-12-10 | Mitraltech Ltd. | Ventricularly-anchored prosthetic valves |
| US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
| US10450480B2 (en) * | 2013-03-13 | 2019-10-22 | Hentzen Coatings, Inc. | Water-reducible single-component moisture-curing polyurethane coatings |
| US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
| US9687346B2 (en) | 2013-03-14 | 2017-06-27 | Edwards Lifesciences Corporation | Multi-stranded heat set annuloplasty rings |
| CN105283214B (en) | 2013-03-15 | 2018-10-16 | 北京泰德制药股份有限公司 | Translate conduit, system and its application method |
| US10149757B2 (en) | 2013-03-15 | 2018-12-11 | Edwards Lifesciences Corporation | System and method for transaortic delivery of a prosthetic heart valve |
| WO2014144247A1 (en) | 2013-03-15 | 2014-09-18 | Arash Kheradvar | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
| US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
| US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
| US10299793B2 (en) | 2013-10-23 | 2019-05-28 | Valtech Cardio, Ltd. | Anchor magazine |
| US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
| US10390943B2 (en) | 2014-03-17 | 2019-08-27 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
| EP3134033B1 (en) | 2014-05-29 | 2018-04-04 | Edwards Lifesciences CardiAQ LLC | Prosthesis and delivery device |
| WO2016059639A1 (en) | 2014-10-14 | 2016-04-21 | Valtech Cardio Ltd. | Leaflet-restraining techniques |
| US10188392B2 (en) | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
| WO2016125160A1 (en) | 2015-02-05 | 2016-08-11 | Mitraltech Ltd. | Prosthetic valve with axially-sliding frames |
| US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
| US10524912B2 (en) | 2015-04-02 | 2020-01-07 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
| CN114515173A (en) | 2015-04-30 | 2022-05-20 | 瓦尔泰克卡迪欧有限公司 | Valvuloplasty techniques |
| US10314707B2 (en) | 2015-06-09 | 2019-06-11 | Edwards Lifesciences, Llc | Asymmetric mitral annuloplasty band |
| US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
| US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
| US10456246B2 (en) | 2015-07-02 | 2019-10-29 | Edwards Lifesciences Corporation | Integrated hybrid heart valves |
| WO2017004369A1 (en) | 2015-07-02 | 2017-01-05 | Edwards Lifesciences Corporation | Hybrid heart valves adapted for post-implant expansion |
| US10667815B2 (en) | 2015-07-21 | 2020-06-02 | Evalve, Inc. | Tissue grasping devices and related methods |
| US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
| US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
| US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
| WO2017117370A2 (en) | 2015-12-30 | 2017-07-06 | Mitralign, Inc. | System and method for reducing tricuspid regurgitation |
| CA3007670A1 (en) | 2016-01-29 | 2017-08-03 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
| US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
| US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
| US10736632B2 (en) | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
| GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
| EP3848003A1 (en) | 2016-08-10 | 2021-07-14 | Cardiovalve Ltd. | Prosthetic valve with concentric frames |
| US11071564B2 (en) | 2016-10-05 | 2021-07-27 | Evalve, Inc. | Cardiac valve cutting device |
| US10722356B2 (en) | 2016-11-03 | 2020-07-28 | Edwards Lifesciences Corporation | Prosthetic mitral valve holders |
| US10363138B2 (en) | 2016-11-09 | 2019-07-30 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
| US10398553B2 (en) | 2016-11-11 | 2019-09-03 | Evalve, Inc. | Opposing disk device for grasping cardiac valve tissue |
| US10426616B2 (en) | 2016-11-17 | 2019-10-01 | Evalve, Inc. | Cardiac implant delivery system |
| WO2018090148A1 (en) | 2016-11-21 | 2018-05-24 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
| US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
| US10314586B2 (en) | 2016-12-13 | 2019-06-11 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
| DE102017002976B4 (en) | 2017-03-28 | 2021-08-26 | Immanuel Albertinen Diakonie Ggmbh | Minimally invasive implantable device for eliminating mitral valve insufficiency in the beating heart and mitral valve implant system |
| US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
| EP3621529A1 (en) | 2017-05-12 | 2020-03-18 | Evalve, Inc. | Long arm valve repair clip |
| CA3073834A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
| US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
| CN116531147A (en) | 2018-01-24 | 2023-08-04 | 爱德华兹生命科学创新(以色列)有限公司 | Contraction of annuloplasty structures |
| EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
| USD944398S1 (en) | 2018-06-13 | 2022-02-22 | Edwards Lifesciences Corporation | Expanded heart valve stent |
| CR20210020A (en) | 2018-07-12 | 2021-07-21 | Valtech Cardio Ltd | Annuloplasty systems and locking tools therefor |
| CA3104687A1 (en) | 2018-07-30 | 2020-02-06 | Edwards Lifesciences Corporation | Minimally-invasive low strain annuloplasty ring |
| EP3876870B1 (en) | 2018-11-08 | 2023-12-20 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
| CA3135753C (en) | 2019-04-01 | 2023-10-24 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
| US11491006B2 (en) | 2019-04-10 | 2022-11-08 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
| AU2020279750B2 (en) | 2019-05-20 | 2023-07-13 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
| EP3986332A4 (en) | 2019-06-20 | 2023-07-19 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
| CA3142906A1 (en) | 2019-10-29 | 2021-05-06 | Valtech Cardio, Ltd. | Annuloplasty and tissue anchor technologies |
| EP4076284A1 (en) | 2019-12-16 | 2022-10-26 | Edwards Lifesciences Corporation | Valve holder assembly with suture looping protection |
| CN115297811A (en) | 2020-02-06 | 2022-11-04 | 爱德华兹生命科学公司 | Annuloplasty band with enhanced flexibility |
| WO2022026219A1 (en) | 2020-07-30 | 2022-02-03 | Edwards Lifesciences Corporation | Adjustable annuloplasty ring and delivery system |
| EP4304529A1 (en) | 2021-03-09 | 2024-01-17 | Edwards Lifesciences Corporation | Annuloplasty ring and tether adjustment system |
| CN117752464A (en) * | 2022-09-19 | 2024-03-26 | 江苏臻亿医疗科技有限公司 | Implant for heart valve annulus repair and delivery device for implant |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2306671A1 (en) | 1975-04-11 | 1976-11-05 | Rhone Poulenc Ind | VALVULAR IMPLANT |
| EP0457842B1 (en) | 1989-02-13 | 1994-07-20 | Baxter International Inc. | Selectively flexible annuloplasty ring |
| US5258021A (en) | 1992-01-27 | 1993-11-02 | Duran Carlos G | Sigmoid valve annuloplasty ring |
| US5306296A (en) | 1992-08-21 | 1994-04-26 | Medtronic, Inc. | Annuloplasty and suture rings |
| FR2708458B1 (en) | 1993-08-03 | 1995-09-15 | Seguin Jacques | Prosthetic ring for cardiac surgery. |
| US5450860A (en) | 1993-08-31 | 1995-09-19 | W. L. Gore & Associates, Inc. | Device for tissue repair and method for employing same |
| JPH11514546A (en) | 1995-11-01 | 1999-12-14 | セント ジュード メディカル，インコーポレイテッド | Bioabsorbable annuloplasty prosthesis |
| EP0860151A1 (en) | 1997-02-25 | 1998-08-26 | Naqeeb Khalid | Cardiac valvular support prosthesis |
| US6250308B1 (en) | 1998-06-16 | 2001-06-26 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
| DE19910233A1 (en) | 1999-03-09 | 2000-09-21 | Jostra Medizintechnik Ag | Anuloplasty prosthesis |
| US6183512B1 (en) | 1999-04-16 | 2001-02-06 | Edwards Lifesciences Corporation | Flexible annuloplasty system |
| US6231602B1 (en) | 1999-04-16 | 2001-05-15 | Edwards Lifesciences Corporation | Aortic annuloplasty ring |
| US6187040B1 (en) | 1999-05-03 | 2001-02-13 | John T. M. Wright | Mitral and tricuspid annuloplasty rings |
| US6797002B2 (en) * | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
| US6368348B1 (en) | 2000-05-15 | 2002-04-09 | Shlomo Gabbay | Annuloplasty prosthesis for supporting an annulus of a heart valve |
| US6419696B1 (en) | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
| ITMI20011012A1 (en) | 2001-05-17 | 2002-11-17 | Ottavio Alfieri | ANNULAR PROSTHESIS FOR MITRAL VALVE |
-
2002
- 2002-07-08 US US10/192,516 patent/US6858039B2/en not_active Expired - Lifetime
-
2003
- 2003-07-03 AU AU2003248833A patent/AU2003248833B2/en not_active Expired
- 2003-07-03 JP JP2004519963A patent/JP4384978B2/en not_active Expired - Lifetime
- 2003-07-03 CA CA2489368A patent/CA2489368C/en not_active Expired - Lifetime
- 2003-07-03 EP EP03763288A patent/EP1519695B1/en not_active Expired - Lifetime
- 2003-07-03 DE DE60308523T patent/DE60308523T2/en not_active Expired - Lifetime
- 2003-07-03 WO PCT/US2003/021208 patent/WO2004004607A1/en active IP Right Grant
- 2003-07-03 BR BRPI0312502-5A patent/BR0312502B1/en active IP Right Grant
- 2003-07-03 AT AT03763288T patent/ATE339934T1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60308523T2 (en) | 2007-02-01 |
| JP2005532119A (en) | 2005-10-27 |
| US6858039B2 (en) | 2005-02-22 |
| AU2003248833A1 (en) | 2004-01-23 |
| US20040006384A1 (en) | 2004-01-08 |
| DE60308523D1 (en) | 2006-11-02 |
| JP4384978B2 (en) | 2009-12-16 |
| EP1519695A1 (en) | 2005-04-06 |
| CA2489368A1 (en) | 2004-01-15 |
| EP1519695B1 (en) | 2006-09-20 |
| BR0312502B1 (en) | 2013-04-30 |
| ATE339934T1 (en) | 2006-10-15 |
| BR0312502A (en) | 2005-04-12 |
| AU2003248833B2 (en) | 2008-12-04 |
| WO2004004607A1 (en) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2489368C (en) | Mitral valve annuloplasty ring having a posterior bow | |
| US7993396B2 (en) | Mitral valve annuloplasty ring having an offset posterior bow | |
| US10166101B2 (en) | Methods for repairing mitral valves | |
| CA2539459C (en) | Annuloplasty rings for repair of abnormal mitral valves | |
| CA2685227C (en) | Inwardly-bowed tricuspid annuloplasty ring | |
| US20180221150A1 (en) | Physiologically harmonized tricuspid annuloplasty ring | |
| US11938027B2 (en) | Asymmetric mitral annuloplasty band | |
| US10583008B2 (en) | Devices and implantation methods for treating mitral valve conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20230704 |